Skip to content

Company
PIpeline
For Investors
Contact

Investors

Press Releases

Choose Year
Search Press Releases

Found 265 Results

February 10, 2022

Relmada Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference

December 22, 2021

Relmada Therapeutics Announces Publication of REL-1017 Phase 2 Study Results in The American Journal of Psychiatry

December 14, 2021

Relmada Therapeutics Announces Closing of Public Offering and Full Exercise of Over-Allotment Option

December 8, 2021

Relmada Therapeutics Announces Proposed Public Offering of Common Stock

December 8, 2021

Relmada Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

December 1, 2021

Relmada Therapeutics to Present Data at the 60th Annual Meeting of the American College of Neuropsychopharmacology

November 11, 2021

Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results

November 9, 2021

Relmada Therapeutics to Present at the Jefferies London Healthcare Conference

November 4, 2021

Relmada Therapeutics to Report Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 11, 2021

October 29, 2021

Relmada Therapeutics to Present Data at the Neuroscience Education Institute Congress

«...8 91011 12 13...»

IR Contact

FIRST NAME LAST NAME
COMPANY NAME
EMAIL@COMPANY.COM

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Unsubscribe

Loading...

Copyright © 2026 Relmada Therapeutics | Powered by Astra WordPress Theme

Scroll to Top